Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2006 | R44 | CA097569 | RFA-CA-06-005 | BRADY, ERIK D | MICROCOSM, INC. | ENHANCED CANCER MICROARRAY | Complete |
2008 | R44 | CA114126 | RFA-CA-07-039 | LIM, MARK | AMBERGEN, INC | ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE | Complete |
2006 | R44 | CA121155 | RFA-CA-06-005 | LU, PETER S. | ARBOR VITA CORPORATION | A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES | Complete |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Complete |
2008 | R44 | CA120619 | RFA-CA-07-041 | LEE, PHILIP J | CELLASIC CORPORATION | MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS | Complete |
2008 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Complete |
2016 | R44 | CA199194 | PAR-13-327 | KARSTEN, STANISLAV | NEUROINDX INC. | Automated Platform for Fixed Tissue Microdissection | Complete |
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Complete |
2016 | R44 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | Next-Generation Antibody Discovery and Development Technology | Complete |
2004 | R44 | CA081903 | PAR-01-106 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS | Complete |
2009 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
2001 | R44 | CA081952 | PAR-99-101 | CHEE, MARK S. | ILLUMINA, INC. | RANDOM ARRAYS FOR GENE EXPRESSION PROFILING | Complete |
2004 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
2009 | R44 | CA115041 | RFA-CA-08-013 | ZOU, NIANXIANG | BIO-QUICK CORPORATION | DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE | Complete |
2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Complete |
2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
1999 | R43 | CA081958 | PAR-98-066 | HAGEN, FREDERICK S | ICOGENEX CORPORATION | AFFINITY AND TRANSCRIPTASE TECHNOLOGIES | Complete |
2007 | R43 | CA126726 | RFA-CA-07-008 | MEDGHALCHI, SUSAN | FASGEN, INC. | FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER | Complete |
2014 | R43 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY | Complete |
2003 | R43 | CA102986 | PAR-01-105 | KRIZMAN, DAVID BURKE | EXPRESSION PATHOLOGY, INC | PROTEIN ARRAYS FOR MOLECULAR ANALYSIS OF CANCER TISSUE | Complete |
2020 | R43 | CA250885 | PAR-18-303 | REDER, NICHOLAS | LIGHTSPEED MICROSCOPY, INC. | Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies | Complete |
2000 | R43 | CA084804 | PAR-99-101 | GOLOVLEV, VAL V | SCI-TEC, INC. | MAGNETIC DISK ARRAY DNA ANALYZER | Complete |
2002 | R43 | CA096079 | PAR-01-105 | HANCOCK, LAWRENCE F | NOMADICS, INC. | POLYMER AMPLIFIED NUCLEIC ACID DETECTION | Complete |
1999 | R43 | CA081962 | PAR-98-066 | GERDES, JOHN CHARLES | XTRANA, INC. | QUANTITATION AND ARCHIVING OF GENE EXPRESSION | Complete |
2007 | R43 | CA128752 | RFA-CA-07-010 | KRAVITZ, RACHEL HANNAH | NEOCLONE BIOTECHNOLOGY INTERNATIONAL | A NOVEL PLATFORM FOR MINING THE REPERTOIRE OF ANTIGEN-SPECIFIC B CELLS | Complete |
2014 | R43 | CA188154 | PAR-13-327 | FELLMANN, CHRISTOF | MIRIMUS, INC. | RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO | Complete |
2003 | R43 | CA103085 | PAR-01-105 | SCHNEIDER, LUKE V | TARGET DISCOVERY | IDBEST DIFFERENTIAL DISPLAY ON PROTEIN CHIPS | Complete |
2000 | R43 | CA086178 | PAR-99-101 | WILLETT, CATHERINE E | PHYLONIX PHARMACEUTICALS, INC. | PHARMACOGENOMICS OF CARCINOGENESIS IN WHOLE ANIMALS | Complete |
2002 | R43 | CA096083 | PAR-01-105 | YANG, CHIHAE | LEADSCOPE, INC. | A NOVEL CHEMICAL GENOMICS METHODOLOGY | Complete |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
1999 | R43 | CA081965 | PAR-98-066 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |
2003 | R43 | CA103086 | PAR-01-105 | BALGLEY, BRIAN M | CALIBRANT BIOSYSTEMS, INC. | ITP-BASED SELECTIVE ENRICHMENT OF LOW ABUNDANCE PROTEINS | Complete |
2000 | R43 | CA086180 | PAR-99-101 | MOEN, PHILLIP T | ONE CELL SYSTEMS, INC | NOVEL METHOD FOR DETECTING NON-HODGKIN'S LYMPHOMA | Complete |
2002 | R43 | CA097447 | PAR-01-105 | TRNOVSKY, JAN | ONE CELL SYSTEMS, INC | METHOD FOR DETECTING CHRONIC MYELOGENOUS LEUKEMIA CELLS | Complete |
2018 | R43 | CA236101 | PAR-18-303 | LEE, LY JAMES | NANOMATERIAL INNOVATION, LTD | Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis | Complete |
1999 | R43 | CA083382 | PAR-98-066 | MONFORTE, JOSEPH A | GENETRACE SYSTEMS, INC. | EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS | Complete |
2017 | R43 | CA214386 | PAR-13-327 | PEYTAVI, REGIS | BLUENOVO BIOSYSTEMS, INC. | Detection of Methylation and Translocation Events by Novel Sequencing Technology | Complete |
2000 | R43 | CA086181 | PAR-99-101 | SERBEDZIJA, GEORGE N | PHYLONIX PHARMACEUTICALS, INC. | WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING | Complete |
2002 | R43 | CA097482 | PAR-01-105 | LATHAM, GARY J | AMBION, INC. | ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA | Complete |
2018 | R43 | CA236142 | PAR-18-303 | SCHOETTLE, LOUIS | GEMNEO BIOSCIENCE, INC. | Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes | Complete |
1999 | R43 | CA083384 | PAR-98-066 | RICHTERICH, PETER | CODONCODE CORPORATION | SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION | Complete |
2020 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations | Active |
2000 | R43 | CA086413 | PAR-99-101 | KOGON, ALEX A | BIOLINX, LLC | THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING | Complete |
2002 | R43 | CA097483 | PAR-01-105 | HANNA, MICHELLE M | RIBOMED BIOTECHNOLOGIES, INC. | RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER | Complete |
2002 | R43 | CA097505 | PAR-01-105 | JOHNSON, PAUL H | EPIGENX PHARMACEUTICALS | TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING | Complete |
2019 | R43 | CA236103 | PAR-18-303 | KHODAVERDIAN, VARANDT Y. | NUPROBE USA, INC. | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | Complete |
1999 | R43 | CA083385 | PAR-98-066 | GOLDRICK, MARIANNA M | AMBION, INC. | DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA | Complete |
2000 | R43 | CA086755 | PAR-99-101 | WOOD, KATHERINE A | TREVIGEN, INC. | HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY | Complete |